We identified ACS patients from our institutional registry who underwent PCI and received either ticagrelor or clopidogrel and compared 1-year all-cause death rates.
The study aim was to evaluate our experience with minimally invasive techniques at a Veterans Affairs Medical Center, since outcomes from lower-volume federal facilities are relatively unknown.